• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮射频消融与开放性部分肾切除术治疗大小和位置匹配的肾肿块的比较。

Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.

机构信息

Department of Urology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea.

出版信息

Int J Hyperthermia. 2012;28(3):227-34. doi: 10.3109/02656736.2012.666319.

DOI:10.3109/02656736.2012.666319
PMID:22515344
Abstract

PURPOSE

To compare percutaneous radiofrequency ablation (RFA) and open partial nephrectomy (OPN) for the treatment of renal cell carcinoma (RCC) with respect to renal function and mid-term oncological outcome.

MATERIALS AND METHODS

From January 2006 to December 2008, 40 (RFA group) and 110 (OPN group) patients underwent RFA and OPN for sporadic RCC, respectively. The sizes and locations of RCCs were matched between the two groups. To determine the lesion size, the maximum transverse diameter was measured. Estimated glomerular filtration rates (eGFR) before and after treatment and overall three-year recurrence-free survival rates were calculated and compared.

RESULTS

Tumours in the RFA and OPN groups ranged from 9-76 mm (24.4 ± 13.1 mm) and from 6-60 mm (22.3 ± 10.2 mm), respectively (p = 0.962). The locations of RCCs were not significantly different (p = 0.101-0.508). The mean reductions of eGFR in the RFA and OPN groups were 2.3 ± 8.6 mL/min/1.73 m² (range, -23 to +17.5 mL/min/1.73 m²) and 7.4 ± 10.9 mL/min/1.73 m² (-23.6 to +42.8 mL/min/1.73 m², respectively (p = 0.013). Overall three-year recurrence-free survival rates in the RFA and OPN groups were 94.7% and 98.9%, respectively (p = 0.266).

CONCLUSION

For treating size- and location-matched RCCs, RFA is superior to OPN with respect to the preservation of renal function. Furthermore, RFA can achieve excellent mid-term outcomes that are equivalent to those of OPN.

摘要

目的

比较经皮射频消融(RFA)和开放性部分肾切除术(OPN)治疗肾细胞癌(RCC)在肾功能和中期肿瘤学结果方面的差异。

材料和方法

2006 年 1 月至 2008 年 12 月,分别有 40 例(RFA 组)和 110 例(OPN 组)接受 RFA 和 OPN 治疗散发性 RCC。两组的 RCC 大小和位置相匹配。为了确定病变大小,测量了最大横径。计算并比较了治疗前后的估算肾小球滤过率(eGFR)和总 3 年无复发生存率。

结果

RFA 和 OPN 组肿瘤大小分别为 9-76mm(24.4±13.1mm)和 6-60mm(22.3±10.2mm)(p=0.962)。RCC 的位置无显著差异(p=0.101-0.508)。RFA 和 OPN 组 eGFR 的平均降低值分别为 2.3±8.6mL/min/1.73m²(范围为-23 至+17.5mL/min/1.73m²)和 7.4±10.9mL/min/1.73m²(-23.6 至+42.8mL/min/1.73m²,p=0.013)。RFA 和 OPN 组的总 3 年无复发生存率分别为 94.7%和 98.9%(p=0.266)。

结论

对于大小和位置相匹配的 RCC,RFA 在保护肾功能方面优于 OPN。此外,RFA 可以实现与 OPN 相当的优异中期结果。

相似文献

1
Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.经皮射频消融与开放性部分肾切除术治疗大小和位置匹配的肾肿块的比较。
Int J Hyperthermia. 2012;28(3):227-34. doi: 10.3109/02656736.2012.666319.
2
Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.孤立肾肿瘤采用消融或切除术治疗的肾功能结果。
BJU Int. 2010 Feb;105(4):496-500. doi: 10.1111/j.1464-410X.2009.08776.x. Epub 2009 Aug 13.
3
Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.腹腔镜与开放性部分肾切除术:200例配对患者的比较
Eur Urol. 2009 May;55(5):1171-8. doi: 10.1016/j.eururo.2009.01.042. Epub 2009 Feb 20.
4
Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.临床T1a期肾肿瘤部分肾切除术与射频消融术的中期比较
BJU Int. 2007 Aug;100(2):287-90. doi: 10.1111/j.1464-410X.2007.06937.x.
5
[Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].[肾肿瘤治疗适应证及必要的保肾手术中射频消融与部分肾切除术的围手术期结果及中期疗效]
Prog Urol. 2013 Feb;23(2):99-104. doi: 10.1016/j.purol.2012.08.269. Epub 2012 Sep 26.
6
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.射频消融治疗 243 个小肾肿瘤 7.5 年的长期肿瘤学结果。
Cancer. 2010 Jul 1;116(13):3135-42. doi: 10.1002/cncr.25002.
7
Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.健康成年人小肾皮质肿瘤的射频消融:肾功能保留及中期肿瘤学结局
BJU Int. 2009 Sep;104(6):786-9. doi: 10.1111/j.1464-410X.2009.08443.x. Epub 2009 Apr 4.
8
RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.RFA 与机器人部分肾切除术治疗 T1a 期肾细胞癌:中期结果的倾向评分匹配比较。
Eur Radiol. 2018 Jul;28(7):2979-2985. doi: 10.1007/s00330-018-5305-6. Epub 2018 Feb 9.
9
Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.T1a 期肾肿瘤射频消融术后健康成年人的长期疗效。
BJU Int. 2014 Jan;113(1):51-5. doi: 10.1111/bju.12366. Epub 2013 Nov 8.
10
Laparoscopic vs open partial nephrectomy for T1 renal tumours: evaluation of long-term oncological and functional outcomes in 340 patients.腹腔镜与开放肾部分切除术治疗 T1 期肾肿瘤:340 例患者长期肿瘤学和功能结局评估。
BJU Int. 2013 Feb;111(2):281-8. doi: 10.1111/j.1464-410X.2012.11280.x. Epub 2012 Jun 6.

引用本文的文献

1
A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching.倾向评分匹配后慢性肾脏病患者行部分肾切除术与射频消融术的功能和肿瘤学结局比较
Diagnostics (Basel). 2022 Sep 23;12(10):2292. doi: 10.3390/diagnostics12102292.
2
Risk Factors for Renal Function Impairment Following Radiofrequency Ablation of Renal Tumors.肾肿瘤射频消融术后肾功能损害的危险因素
Taehan Yongsang Uihakhoe Chi. 2022 Mar;83(2):317-330. doi: 10.3348/jksr.2021.0076. Epub 2022 Dec 11.
3
Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
重复经皮射频消融治疗 von Hippel-Lindau 病患者 T1 期肾细胞癌是安全的。
Cardiovasc Intervent Radiol. 2021 Dec;44(12):2022-2025. doi: 10.1007/s00270-021-02935-w. Epub 2021 Aug 19.
4
Asian Conference on Tumor Ablation guidelines for renal cell carcinoma.亚洲肿瘤消融治疗肾癌专家共识
Investig Clin Urol. 2021 Jul;62(4):378-388. doi: 10.4111/icu.20210168.
5
Comparative outcomes of radio frequency ablation versus partial nephrectomy for T1 renal tumors: a systematic review.T1期肾肿瘤射频消融与部分肾切除术的比较结果:一项系统评价
Transl Androl Urol. 2019 Dec;8(6):601-608. doi: 10.21037/tau.2019.10.13.
6
Are the long-term outcomes of percutaneous ablation for clinical stage T1 renal tumors similar to those of partial nephrectomy?临床分期为T1期的肾肿瘤经皮消融的长期疗效与部分肾切除术的长期疗效相似吗?
Ann Transl Med. 2019 Dec;7(Suppl 8):S370. doi: 10.21037/atm.2019.08.106.
7
Systematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards.T1期肾细胞癌管理的当代证据系统评价:肾癌肿瘤委员会的介入放射科医生需要了解的内容
Semin Intervent Radiol. 2019 Aug;36(3):194-202. doi: 10.1055/s-0039-1693119. Epub 2019 Aug 19.
8
Prospective evaluation of CT-guided HDR brachytherapy as a local ablative treatment for renal masses: a single-arm pilot trial.前瞻性评估 CT 引导下 HDR 近距离放疗治疗肾肿瘤:单臂试验研究。
Strahlenther Onkol. 2019 Nov;195(11):982-990. doi: 10.1007/s00066-019-01501-1. Epub 2019 Jul 25.
9
Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.GU 癌症中的保器官手术:第 1 部分-肾脏和肾上腺肿瘤中的保器官手术:系统评价。
Int Urol Nephrol. 2019 Mar;51(3):377-393. doi: 10.1007/s11255-018-02070-5. Epub 2019 Jan 8.
10
Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis.部分肾切除术与消融技术治疗小肾肿瘤的比较:系统评价和网络荟萃分析。
Eur Radiol. 2019 Mar;29(3):1293-1307. doi: 10.1007/s00330-018-5660-3. Epub 2018 Sep 25.